nodes	percent_of_prediction	percent_of_DWPC	metapath
Anisotropine Methylbromide—Valproic Acid—epilepsy syndrome	0.64	1	CrCtD
Anisotropine Methylbromide—CHRM3—epilepsy syndrome	0.119	0.371	CbGaD
Anisotropine Methylbromide—CHRM1—epilepsy syndrome	0.111	0.346	CbGaD
Anisotropine Methylbromide—CHRM2—epilepsy syndrome	0.0903	0.283	CbGaD
Anisotropine Methylbromide—Valproic Acid—ABAT—epilepsy syndrome	0.000864	0.342	CrCbGaD
Anisotropine Methylbromide—Homatropine Methylbromide—CHRM3—epilepsy syndrome	0.000276	0.109	CrCbGaD
Anisotropine Methylbromide—Homatropine Methylbromide—CHRM1—epilepsy syndrome	0.000257	0.102	CrCbGaD
Anisotropine Methylbromide—Ipratropium bromide—CHRM3—epilepsy syndrome	0.000246	0.0972	CrCbGaD
Anisotropine Methylbromide—Ipratropium bromide—CHRM1—epilepsy syndrome	0.000229	0.0907	CrCbGaD
Anisotropine Methylbromide—Homatropine Methylbromide—CHRM2—epilepsy syndrome	0.00021	0.0831	CrCbGaD
Anisotropine Methylbromide—Ipratropium bromide—CHRM2—epilepsy syndrome	0.000187	0.074	CrCbGaD
Anisotropine Methylbromide—Valproic Acid—CYP2C19—epilepsy syndrome	0.000173	0.0686	CrCbGaD
Anisotropine Methylbromide—Ipratropium bromide—CYP2D6—epilepsy syndrome	8.56e-05	0.0339	CrCbGaD
Anisotropine Methylbromide—CHRM3—Metabolism—ABCG2—epilepsy syndrome	7.26e-06	0.000193	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCR downstream signaling—AVP—epilepsy syndrome	7.22e-06	0.000192	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—CX3CR1—epilepsy syndrome	7.16e-06	0.00019	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—CX3CR1—epilepsy syndrome	7.14e-06	0.00019	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—CYP2C19—epilepsy syndrome	7.07e-06	0.000188	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—CX3CR1—epilepsy syndrome	7.07e-06	0.000188	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—CYP11A1—epilepsy syndrome	7.03e-06	0.000187	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—BDKRB1—epilepsy syndrome	7.02e-06	0.000186	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—CHRM2—epilepsy syndrome	7.02e-06	0.000186	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—CX3CL1—epilepsy syndrome	7.02e-06	0.000186	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—BDKRB1—epilepsy syndrome	7e-06	0.000186	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—CHRM2—epilepsy syndrome	7e-06	0.000186	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—CX3CL1—epilepsy syndrome	7e-06	0.000186	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—BDKRB1—epilepsy syndrome	6.93e-06	0.000184	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—CX3CL1—epilepsy syndrome	6.93e-06	0.000184	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—CDC42—epilepsy syndrome	6.86e-06	0.000182	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—CDC42—epilepsy syndrome	6.84e-06	0.000182	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—GABBR1—epilepsy syndrome	6.83e-06	0.000181	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—GABBR1—epilepsy syndrome	6.81e-06	0.000181	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—CDC42—epilepsy syndrome	6.77e-06	0.00018	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—GABBR1—epilepsy syndrome	6.74e-06	0.000179	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—AVP—epilepsy syndrome	6.64e-06	0.000176	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—AVP—epilepsy syndrome	6.62e-06	0.000176	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—AVP—epilepsy syndrome	6.56e-06	0.000174	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—HRH3—epilepsy syndrome	6.55e-06	0.000174	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—HRH3—epilepsy syndrome	6.53e-06	0.000173	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—HRH3—epilepsy syndrome	6.46e-06	0.000172	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—OPRM1—epilepsy syndrome	6.45e-06	0.000171	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—OPRM1—epilepsy syndrome	6.43e-06	0.000171	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—OPRM1—epilepsy syndrome	6.36e-06	0.000169	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—CYP2D6—epilepsy syndrome	6.34e-06	0.000168	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—GPCR downstream signaling—CCR5—epilepsy syndrome	6.22e-06	0.000165	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCR downstream signaling—CCR5—epilepsy syndrome	6.2e-06	0.000165	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCR downstream signaling—CCR5—epilepsy syndrome	6.14e-06	0.000163	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—CCR3—epilepsy syndrome	6.09e-06	0.000162	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—GPCR downstream signaling—HTR2A—epilepsy syndrome	6.09e-06	0.000162	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—CCR3—epilepsy syndrome	6.07e-06	0.000161	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCR downstream signaling—HTR2A—epilepsy syndrome	6.07e-06	0.000161	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—ADRA2A—epilepsy syndrome	6.04e-06	0.00016	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—BCHE—epilepsy syndrome	6.01e-06	0.00016	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—CCR3—epilepsy syndrome	6.01e-06	0.00016	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCR downstream signaling—HTR2A—epilepsy syndrome	6.01e-06	0.00016	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—NPY—epilepsy syndrome	5.93e-06	0.000158	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—ATP2A2—epilepsy syndrome	5.93e-06	0.000158	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—NPY—epilepsy syndrome	5.91e-06	0.000157	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—ATP2A2—epilepsy syndrome	5.91e-06	0.000157	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—NPY—epilepsy syndrome	5.86e-06	0.000156	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—ATP2A2—epilepsy syndrome	5.86e-06	0.000156	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—GPCR downstream signaling—AGT—epilepsy syndrome	5.77e-06	0.000153	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCR downstream signaling—AGT—epilepsy syndrome	5.76e-06	0.000153	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—SLC2A1—epilepsy syndrome	5.74e-06	0.000152	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—OXT—epilepsy syndrome	5.72e-06	0.000152	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—CXCL2—epilepsy syndrome	5.72e-06	0.000152	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—CRH—epilepsy syndrome	5.72e-06	0.000152	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—CCL3—epilepsy syndrome	5.72e-06	0.000152	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—HSPB1—epilepsy syndrome	5.72e-06	0.000152	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—CCL3—epilepsy syndrome	5.71e-06	0.000152	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—OXT—epilepsy syndrome	5.71e-06	0.000152	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—CXCL2—epilepsy syndrome	5.71e-06	0.000152	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—HSPB1—epilepsy syndrome	5.71e-06	0.000152	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—CRH—epilepsy syndrome	5.71e-06	0.000152	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCR downstream signaling—AGT—epilepsy syndrome	5.7e-06	0.000151	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—PLCB1—epilepsy syndrome	5.67e-06	0.000151	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—TH—epilepsy syndrome	5.65e-06	0.00015	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—HSPB1—epilepsy syndrome	5.65e-06	0.00015	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—CRH—epilepsy syndrome	5.65e-06	0.00015	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—CXCL2—epilepsy syndrome	5.65e-06	0.00015	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—OXT—epilepsy syndrome	5.65e-06	0.00015	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—CCL3—epilepsy syndrome	5.65e-06	0.00015	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—CCR5—epilepsy syndrome	5.65e-06	0.00015	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—CCR5—epilepsy syndrome	5.63e-06	0.00015	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—CCR5—epilepsy syndrome	5.57e-06	0.000148	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—HTR2A—epilepsy syndrome	5.53e-06	0.000147	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—HTR2A—epilepsy syndrome	5.51e-06	0.000146	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—HTR2A—epilepsy syndrome	5.46e-06	0.000145	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—GPCR downstream signaling—PRKCB—epilepsy syndrome	5.34e-06	0.000142	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—TSC1—epilepsy syndrome	5.32e-06	0.000141	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—PTK2B—epilepsy syndrome	5.32e-06	0.000141	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCR downstream signaling—PRKCB—epilepsy syndrome	5.32e-06	0.000141	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—TSC1—epilepsy syndrome	5.3e-06	0.000141	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—PTK2B—epilepsy syndrome	5.3e-06	0.000141	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCR downstream signaling—PRKCB—epilepsy syndrome	5.27e-06	0.00014	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—PTK2B—epilepsy syndrome	5.25e-06	0.00014	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—TSC1—epilepsy syndrome	5.25e-06	0.00014	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—AGT—epilepsy syndrome	5.24e-06	0.000139	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—AGT—epilepsy syndrome	5.23e-06	0.000139	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—CCR2—epilepsy syndrome	5.18e-06	0.000137	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—NTRK2—epilepsy syndrome	5.18e-06	0.000137	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—SST—epilepsy syndrome	5.18e-06	0.000137	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—AGT—epilepsy syndrome	5.18e-06	0.000137	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—NTRK2—epilepsy syndrome	5.16e-06	0.000137	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—CCR2—epilepsy syndrome	5.16e-06	0.000137	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—SST—epilepsy syndrome	5.16e-06	0.000137	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—DUSP6—epilepsy syndrome	5.13e-06	0.000136	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—DUSP6—epilepsy syndrome	5.12e-06	0.000136	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—NTRK2—epilepsy syndrome	5.11e-06	0.000136	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—CCR2—epilepsy syndrome	5.11e-06	0.000136	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—SST—epilepsy syndrome	5.11e-06	0.000136	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—ADRA2A—epilepsy syndrome	5.07e-06	0.000135	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—DUSP6—epilepsy syndrome	5.07e-06	0.000135	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—ADRA2A—epilepsy syndrome	5.05e-06	0.000134	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—PLAT—epilepsy syndrome	5.04e-06	0.000134	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—PLAT—epilepsy syndrome	5.03e-06	0.000134	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—ADRA2A—epilepsy syndrome	5e-06	0.000133	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—PLAT—epilepsy syndrome	4.98e-06	0.000132	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—BDKRB2—epilepsy syndrome	4.87e-06	0.000129	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—CXCL12—epilepsy syndrome	4.87e-06	0.000129	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—GPCR downstream signaling—POMC—epilepsy syndrome	4.86e-06	0.000129	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—BDKRB2—epilepsy syndrome	4.85e-06	0.000129	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—CXCL12—epilepsy syndrome	4.85e-06	0.000129	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—PRKCB—epilepsy syndrome	4.84e-06	0.000129	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCR downstream signaling—POMC—epilepsy syndrome	4.84e-06	0.000129	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—PRKCB—epilepsy syndrome	4.83e-06	0.000128	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—IL6ST—epilepsy syndrome	4.83e-06	0.000128	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—IL6ST—epilepsy syndrome	4.81e-06	0.000128	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—CXCL12—epilepsy syndrome	4.8e-06	0.000128	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—BDKRB2—epilepsy syndrome	4.8e-06	0.000128	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCR downstream signaling—POMC—epilepsy syndrome	4.8e-06	0.000127	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—PRKCB—epilepsy syndrome	4.78e-06	0.000127	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—JUNB—epilepsy syndrome	4.78e-06	0.000127	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—CNR1—epilepsy syndrome	4.78e-06	0.000127	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—IL6ST—epilepsy syndrome	4.76e-06	0.000127	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—JUNB—epilepsy syndrome	4.76e-06	0.000126	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—CNR1—epilepsy syndrome	4.76e-06	0.000126	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—PLCB1—epilepsy syndrome	4.76e-06	0.000126	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—PLCB1—epilepsy syndrome	4.75e-06	0.000126	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—HMOX1—epilepsy syndrome	4.72e-06	0.000125	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—CNR1—epilepsy syndrome	4.72e-06	0.000125	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—JUNB—epilepsy syndrome	4.72e-06	0.000125	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—PLCB1—epilepsy syndrome	4.7e-06	0.000125	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—HTR7—epilepsy syndrome	4.66e-06	0.000124	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—CAT—epilepsy syndrome	4.66e-06	0.000124	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—HTR7—epilepsy syndrome	4.65e-06	0.000123	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—HTR7—epilepsy syndrome	4.6e-06	0.000122	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—ABCB1—epilepsy syndrome	4.53e-06	0.00012	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—HBEGF—epilepsy syndrome	4.52e-06	0.00012	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—HBEGF—epilepsy syndrome	4.51e-06	0.00012	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—HBEGF—epilepsy syndrome	4.47e-06	0.000119	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—AKT3—epilepsy syndrome	4.44e-06	0.000118	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—AKT3—epilepsy syndrome	4.43e-06	0.000118	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—POMC—epilepsy syndrome	4.41e-06	0.000117	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—POMC—epilepsy syndrome	4.4e-06	0.000117	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—AKT3—epilepsy syndrome	4.38e-06	0.000116	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—POMC—epilepsy syndrome	4.36e-06	0.000116	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—ADAM10—epilepsy syndrome	4.34e-06	0.000115	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—ADAM10—epilepsy syndrome	4.32e-06	0.000115	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—CCL2—epilepsy syndrome	4.32e-06	0.000115	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—CCL2—epilepsy syndrome	4.3e-06	0.000114	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—ADAM10—epilepsy syndrome	4.28e-06	0.000114	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—CCL2—epilepsy syndrome	4.26e-06	0.000113	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—GPX1—epilepsy syndrome	4.21e-06	0.000112	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—S100B—epilepsy syndrome	4.1e-06	0.000109	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—S100B—epilepsy syndrome	4.09e-06	0.000109	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—SOCS3—epilepsy syndrome	4.06e-06	0.000108	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—CDC42—epilepsy syndrome	4.05e-06	0.000108	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—S100B—epilepsy syndrome	4.05e-06	0.000108	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—SOCS3—epilepsy syndrome	4.05e-06	0.000108	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—CDC42—epilepsy syndrome	4.04e-06	0.000107	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—SOCS3—epilepsy syndrome	4.01e-06	0.000107	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—CDC42—epilepsy syndrome	4e-06	0.000106	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—AVP—epilepsy syndrome	3.92e-06	0.000104	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—AVP—epilepsy syndrome	3.91e-06	0.000104	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—AVP—epilepsy syndrome	3.87e-06	0.000103	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—HES1—epilepsy syndrome	3.71e-06	9.85e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—HES1—epilepsy syndrome	3.7e-06	9.82e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—AGT—epilepsy syndrome	3.69e-06	9.81e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—HES1—epilepsy syndrome	3.66e-06	9.73e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—APOE—epilepsy syndrome	3.62e-06	9.61e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—FYN—epilepsy syndrome	3.61e-06	9.58e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—FYN—epilepsy syndrome	3.6e-06	9.55e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—H2AFX—epilepsy syndrome	3.59e-06	9.55e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—MEF2C—epilepsy syndrome	3.59e-06	9.53e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—H2AFX—epilepsy syndrome	3.58e-06	9.52e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—MEF2C—epilepsy syndrome	3.58e-06	9.5e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—FYN—epilepsy syndrome	3.56e-06	9.46e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—H2AFX—epilepsy syndrome	3.55e-06	9.42e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—MEF2C—epilepsy syndrome	3.54e-06	9.41e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—YWHAZ—epilepsy syndrome	3.47e-06	9.21e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—YWHAZ—epilepsy syndrome	3.46e-06	9.18e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—NGF—epilepsy syndrome	3.43e-06	9.11e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—YWHAZ—epilepsy syndrome	3.42e-06	9.09e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—NGF—epilepsy syndrome	3.42e-06	9.08e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—NGF—epilepsy syndrome	3.39e-06	8.99e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—CCR5—epilepsy syndrome	3.34e-06	8.86e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—CCR5—epilepsy syndrome	3.33e-06	8.83e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—CCR5—epilepsy syndrome	3.29e-06	8.75e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—HTR2A—epilepsy syndrome	3.26e-06	8.67e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—HTR2A—epilepsy syndrome	3.25e-06	8.64e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—HTR2A—epilepsy syndrome	3.22e-06	8.56e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—POMC—epilepsy syndrome	3.11e-06	8.25e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—TSC2—epilepsy syndrome	3.1e-06	8.24e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—AGT—epilepsy syndrome	3.1e-06	8.23e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—TSC2—epilepsy syndrome	3.09e-06	8.21e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—AGT—epilepsy syndrome	3.09e-06	8.2e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—TSC2—epilepsy syndrome	3.06e-06	8.13e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—AGT—epilepsy syndrome	3.06e-06	8.12e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—APOE—epilepsy syndrome	3.03e-06	8.06e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—APOE—epilepsy syndrome	3.03e-06	8.03e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—APOE—epilepsy syndrome	3e-06	7.96e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—KDR—epilepsy syndrome	2.97e-06	7.9e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—KDR—epilepsy syndrome	2.96e-06	7.87e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—KDR—epilepsy syndrome	2.94e-06	7.8e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—PRKCB—epilepsy syndrome	2.86e-06	7.6e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—PRKCB—epilepsy syndrome	2.85e-06	7.58e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—IL6ST—epilepsy syndrome	2.85e-06	7.57e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—IL6ST—epilepsy syndrome	2.84e-06	7.55e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—ALB—epilepsy syndrome	2.83e-06	7.53e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—PRKCB—epilepsy syndrome	2.83e-06	7.5e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—IL6ST—epilepsy syndrome	2.81e-06	7.47e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—POMC—epilepsy syndrome	2.61e-06	6.92e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—POMC—epilepsy syndrome	2.6e-06	6.9e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—POMC—epilepsy syndrome	2.57e-06	6.84e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—CCL2—epilepsy syndrome	2.55e-06	6.78e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—CCL2—epilepsy syndrome	2.54e-06	6.75e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—CCL2—epilepsy syndrome	2.52e-06	6.69e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—PTGS2—epilepsy syndrome	2.48e-06	6.58e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—FGF2—epilepsy syndrome	2.31e-06	6.12e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—FGF2—epilepsy syndrome	2.3e-06	6.1e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—FGF2—epilepsy syndrome	2.28e-06	6.04e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—RELA—epilepsy syndrome	2.14e-06	5.68e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—RELA—epilepsy syndrome	2.13e-06	5.67e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—RELA—epilepsy syndrome	2.11e-06	5.61e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—MTOR—epilepsy syndrome	2.1e-06	5.57e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—MTOR—epilepsy syndrome	2.09e-06	5.56e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—MTOR—epilepsy syndrome	2.07e-06	5.5e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—GPCR downstream signaling—AKT1—epilepsy syndrome	1.95e-06	5.17e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—GPCR downstream signaling—AKT1—epilepsy syndrome	1.94e-06	5.16e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—CASP3—epilepsy syndrome	1.93e-06	5.13e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—CASP3—epilepsy syndrome	1.92e-06	5.11e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—GPCR downstream signaling—AKT1—epilepsy syndrome	1.92e-06	5.11e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—CASP3—epilepsy syndrome	1.91e-06	5.06e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—JUN—epilepsy syndrome	1.87e-06	4.98e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—JUN—epilepsy syndrome	1.87e-06	4.96e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—JUN—epilepsy syndrome	1.85e-06	4.92e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—MMP9—epilepsy syndrome	1.82e-06	4.84e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—MMP9—epilepsy syndrome	1.82e-06	4.83e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—MMP9—epilepsy syndrome	1.8e-06	4.78e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling by GPCR—AKT1—epilepsy syndrome	1.77e-06	4.7e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling by GPCR—AKT1—epilepsy syndrome	1.76e-06	4.68e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling by GPCR—AKT1—epilepsy syndrome	1.75e-06	4.64e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—SRC—epilepsy syndrome	1.68e-06	4.47e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—SRC—epilepsy syndrome	1.68e-06	4.45e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—SRC—epilepsy syndrome	1.66e-06	4.41e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—VEGFA—epilepsy syndrome	1.64e-06	4.35e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—VEGFA—epilepsy syndrome	1.63e-06	4.34e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—VEGFA—epilepsy syndrome	1.62e-06	4.29e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Metabolism—AKT1—epilepsy syndrome	1.25e-06	3.31e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM1—Signaling Pathways—AKT1—epilepsy syndrome	1.05e-06	2.78e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM3—Signaling Pathways—AKT1—epilepsy syndrome	1.04e-06	2.77e-05	CbGpPWpGaD
Anisotropine Methylbromide—CHRM2—Signaling Pathways—AKT1—epilepsy syndrome	1.03e-06	2.74e-05	CbGpPWpGaD
